Core Scientific (CORZ) Revenue (2021 - 2026)

Core Scientific has disclosed Revenue across 6 years of filings, most recently posting $115.2 million for Q1 2026.

• Revenue for Q1 2026 came in at $115.2 million, up 44.92% year-over-year; the trailing twelve-month figure through Mar 2026 was $354.7 million (down 13.67% YoY), and the FY2025 annual result was $319.0 million, down 37.53% from the prior year.
• Revenue came in at $115.2 million for Q1 2026 at Core Scientific, up from $79.8 million in the prior quarter.
• In the past five years, Revenue ranged from a high of $192.5 million in Q1 2022 to a low of $78.6 million in Q2 2025.
• The 5-year median for Revenue is $120.7 million (2023), against an average of $122.8 million.
• Peak annual rise in Revenue reached 254.9% in 2022, while the deepest fall reached 59.82% in 2022.
• Core Scientific's Revenue stood at $121.2 million in 2022, then increased by 17.05% to $141.9 million in 2023, then plunged by 33.12% to $94.9 million in 2024, then retreated by 15.97% to $79.8 million in 2025, then surged by 44.48% to $115.2 million in 2026.
• The last three Revenue figures came in at $115.2 million (Q1 2026), $79.8 million (Q4 2025), and $81.1 million (Q3 2025), per Business Quant data.